The pharmaceutical company's Social Impact Venture Capital Portfolio helps improve healthcare access for black and other minority groups in the US.

Sumitomo Mitsui Banking Corporation’s $200m SMBC Asia Rising Fund will back fintech companies in Southeast Asia and India.

Education provider Globis closed its seventh VC fund at $543m while Heritage Medical Systems, Exor and Alexandria participated in RNA drug developer Orbital’s $270m series A round.

Axa IM Alts co-led a $106.5m round for bacterial therapeutics startup Vedanta while Bloomberg Beta participated in generative AI developer Replit’s $97.4m series B.

Telstra Ventures helped savings app developer Super raise $85m while ING Ventures was part of database software producer Weaviate's $50m series B.

Amazon, Munich Re and Qualcomm backed the second tranche of Span's latest round, while Associated British Foods helped lift KoRo’s series B to $82.7m.

GAC Group took part in the battery material producer’s $375m series B round while MetaVC Partners’ $62m fund included Corning and JSR as LPs.

The trading group's Marunouchi Capital unit reached its first close while BMS and Alexandria took part in cancer drug developer Torl’s $150m series B round.

The insurer is following up a $50m first fund with a sophomore vehicle that will continue to invest in Massachusetts-based startups along with those led by black founders.

Bitget’s Asia-focused BitGet Web3 Fund has been equipped with $100m while Hype has received $10m in a series A round featuring Bloomberg.